Increased expression of miR-223-3p and mir-7-5p does not decrease the expression of NLRP3 inflammasome and IL-1 and IL-18 production significantly in LPS primed and Aβ42-stimulated PBMC of AD patients (La Rosa et al. 2021). Here, NLRP3 is linked to Alzheimer disease.